Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices

    Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices

    Medical Dialogues Bureau8 Jun 2019 2:35 PM IST
    As per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
    Torrent Pharma posts Q4 net loss of Rs 152 crore

    Torrent Pharma posts Q4 net loss of Rs 152 crore

    Garima24 May 2019 9:15 AM IST
    The company had posted a net profit of Rs 228 crore for the corresponding period of the previous fiscal, Torrent Pharma said in a filing to the...
    Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4

    Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4

    Garima19 May 2019 9:30 AM IST
    Jubilant Life Sciences said its bottom line in the quarter was hit by a one-time loan settlement with IFC, that resulted in an exceptional item of Rs...
    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Farhat Nasim9 May 2019 10:15 AM IST
    Unichem Lab's approved drug is a generic copy of Zyrtec-D 12 Hour which is used for treating allergic rhinitis.New Delhi: Unichem Laboratories Tuesday...
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Farhat Nasim8 May 2019 10:15 AM IST
    Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Farhat Nasim6 May 2019 10:00 AM IST
    Lupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to "failed impurities/degradation...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 9:15 AM IST
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Farhat Nasim5 May 2019 10:00 AM IST
    Emgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Farhat Nasim4 May 2019 10:00 AM IST
    The US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court

    Meghna A Singhania3 May 2019 1:50 PM IST
    Mumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok